Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [ChIP-seq]

ABSTRACT: ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [ChIP-seq]

PROVIDER: PRJNA752731 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15365231_1.fastq.gz	Fastqsanger.gz
	SRR15365231_2.fastq.gz	Fastqsanger.gz
	SRR15365232_1.fastq.gz	Fastqsanger.gz
	SRR15365232_2.fastq.gz	Fastqsanger.gz
	SRR15365233_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 52

Similar Datasets

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia

Project description:ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia

| PRJNA752213 | ENA

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [HiChIP]

Project description:ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [HiChIP]

| PRJNA752217 | ENA

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [RNA-Seq]

Project description:ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [RNA-Seq]

| PRJNA752371 | ENA

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [scRNA-Seq]

Project description:ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [scRNA-Seq]

| PRJNA752175 | ENA

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [RNA-seq 2]

Project description:ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [RNA-seq 2]

| PRJNA789404 | ENA

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia

Project description:ZNF384-rearranged fusion oncoproteins (FO) define a subset of lineage ambiguous leukemias, but the mechanistic role of ZNF384 FO in leukemogenesis and lineage ambiguity is poorly understood. Here, using viral expression in mouse and human hematopoietic stem and progenitor cells (HSPCs) and a Ep300-Zfp384 mouse model we show that ZNF384 FO promote hematopoietic expansion, myeloid lineage skewing, and self-renewal. In mouse HSPCs, concomitant lesions such as NRASG12D, were required for fully penetrant leukemia, whereas expression of ZNF384 FO drove development of B/myeloid leukemia in human HSPCs, with sensitivity of human ZNF384r leukemia to FLT3 inhibition in vivo. Mechanistically, ZNF384 FO occupy a subset of predominantly intragenic/enhancer regions with increased histone 3 lysine acetylation suggesting enhancer function. These data define a paradigm for FO-driven lineage ambiguous leukemia, in which expression in HSPCs results in deregulation of lineage-specific genes and hematopoietic skewing, progressing to full leukemic transformation in the presence of proliferative stress.

2022-03-16 | PXD028481 | Pride

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [ChIP-seq]

Project description:We report changes in chromatin occupancy dependent on TCF3-ZNF384 splicing isoform usage. The isoform including exon 8, which encodes 2 zinc finger domains, has increased binding near genes important for nomal hematopoiesis. We report no global changes in H3K27Ac upon expression of ZNF384 fusions but 47 loci with increased H3K27Ac.

2022-08-31 | GSE181617 | GEO

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [HiChIP]

Project description:We report no global changes in H3K27Ac upon expression of ZNF384 fusions but 47 loci with increased H3K27Ac. Therefore we performed HiChIP H3K27Ac to determine if those loci are enhancers. We did not observe any differential looping.

2022-08-31 | GSE181498 | GEO

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [RNA-Seq]

Project description:RNA-seq of multiple models of ZNF384-rearrangments (transplanted human CD34 cells and transplanted mouse lineage negative cells) to determine differentially expressed genes.

2022-08-31 | GSE181532 | GEO

ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia [scRNA-Seq]

Project description:Expression of ZNF384 fusions results in lineage abberancy and leukemia development. Here we report the gene expression changes that occur in the hematopoietic system when Ep300-Zfp384 is expressed in a transgenic mouse model.

2022-08-31 | GSE181495 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data